These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 828980)

  • 1. Chronic industrial exposure to lead in 63 subjects. II. Evaluation of chelation therapy.
    Strickland GT; Hwang YF; Chang NK; Blackwell RQ
    Southeast Asian J Trop Med Public Health; 1976 Dec; 7(4):569-74. PubMed ID: 828980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mobilization of lead in patients with chronic poisoning by that metal. Oral penicillamine].
    González-Ramírez D; Zuñiga-Charles M; Narro-Juárez A
    Arch Invest Med (Mex); 1990; 21(3):279-83. PubMed ID: 2131778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
    Lin JL; Lin-Tan DT; Hsu KH; Yu CC
    N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chelation therapy in children with subclinical plumbism.
    Chisolm JJ
    Pediatrics; 1974 Mar; 53(3):441-3. PubMed ID: 4205583
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of lead poisoning.
    Med Lett Drugs Ther; 1972 Feb; 14(3):5-7. PubMed ID: 4630751
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative therapeutic study of low-dose d-penicillamine and disodium calcium EDTA in lead poisoning of acute nature].
    Cartón JA; Llorente R; Arribas JM; Cabeza JM; Cárcaba V; Asensi V
    Med Clin (Barc); 1985 Nov; 85(17):695-8. PubMed ID: 3937003
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-level environmental exposure to lead and progressive chronic kidney diseases.
    Lin JL; Lin-Tan DT; Li YJ; Chen KH; Huang YL
    Am J Med; 2006 Aug; 119(8):707.e1-9. PubMed ID: 16887418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult lead poisoning.
    Zatlin GS; Senaldi EM; Bruckheim AH
    Am Fam Physician; 1985 Oct; 32(4):137-43. PubMed ID: 3931445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychologic and postural sway improvement after Ca(++)-EDTA chelation for mild lead intoxication.
    Linz DH; Barrett ET; Pflaumer JE; Keith RE
    J Occup Med; 1992 Jun; 34(6):638-41. PubMed ID: 1619495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcinosis at the site of leakage from extravasation of calcium disodium edetate intravenous chelator therapy in a child with lead poisoning.
    Schumacher HR; Osterman AL; Choi SJ; Weisz PB
    Clin Orthop Relat Res; 1987 Jun; (219):221-5. PubMed ID: 3107862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
    Yang SK; Xiao L; Song PA; Xu XX; Liu FY; Sun L
    Nephrology (Carlton); 2014 Jan; 19(1):56-9. PubMed ID: 24341661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of initial results of treatment of lead poisoning with EDTA].
    Petkova V; Adjarov D; Pavlova S; Naydenova E; Kerimova M; Kuneva T
    Med Lav; 1994; 85(4):299-308. PubMed ID: 7808345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead, zinc and copper decorporation during calcium disodium ethylenediamine tetraacetate treatment of lead-poisoned children.
    Thomas DJ; Chisolm J
    J Pharmacol Exp Ther; 1986 Dec; 239(3):829-35. PubMed ID: 3098962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of lead nephropathy due to chronic occupational lead exposure].
    Ogata A; Sueta S; Tagawa M
    Nihon Jinzo Gakkai Shi; 2011; 53(2):207-11. PubMed ID: 21516708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of childhood lead poisoning: a survey.
    Glotzer DE; Bauchner H
    Pediatrics; 1992 Apr; 89(4 Pt 1):614-8. PubMed ID: 1313555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of saturnism with a low dose of calcium disodium EDTA].
    Montoya-Cabrera MA; Maldonado-Torres L; Velázwuez-Gutiérrez L; Falcon de la Barrera G
    Arch Invest Med (Mex); 1974; 5(3):603-8. PubMed ID: 4218477
    [No Abstract]   [Full Text] [Related]  

  • 17. Beneficial effects of zinc supplementation during chelation treatment of lead intoxication in rats.
    Flora SJ; Tandon SK
    Toxicology; 1990 Nov; 64(2):129-39. PubMed ID: 2171159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chelation therapy in lead nephropathy.
    Morgan JM
    South Med J; 1975 Aug; 68(8):1001-6. PubMed ID: 125923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental lead exposure and chronic renal disease.
    Owda AK; Alam MG; Shah SV
    N Engl J Med; 2003 May; 348(18):1810-2; author reply 1810-2. PubMed ID: 12724490
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of methionine supplementation in chelation of lead in rats.
    Kachru DN; Khandelwal S; Tandon SK
    Biomed Environ Sci; 1989 Sep; 2(3):265-70. PubMed ID: 2514724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.